Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

171 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Prospective multicenter phase II study of irinotecan as third-line therapy in metastatic colorectal cancer and progression after bolus and infusional 5-fluorouracil.
Hartmann JT, Oechsle K, Jäger E, Reis HE, Haag C, Niederle N, Wilke HJ, Pflüger KH, Batran SA, Büchele T, Hofheinz RD, Kanz L, Bokemeyer C. Hartmann JT, et al. Among authors: hofheinz rd. Anticancer Drugs. 2004 Jun;15(5):473-7. doi: 10.1097/01.cad.0000127144.73043.57. Anticancer Drugs. 2004. PMID: 15166621 Clinical Trial.
Pegylated liposomal doxorubicin and mitomycin C in combination with infusional 5-fluorouracil and sodium folinic acid in the treatment of advanced gastric cancer: results of a phase II trial.
Gnad-Vogt SU, Hofheinz RD, Saussele S, Kreil S, Willer A, Willeke F, Pilz L, Hehlmann R, Hochhaus A. Gnad-Vogt SU, et al. Among authors: hofheinz rd. Anticancer Drugs. 2005 Apr;16(4):435-40. doi: 10.1097/00001813-200504000-00010. Anticancer Drugs. 2005. PMID: 15746580 Clinical Trial.
Liposomal encapsulated anti-cancer drugs.
Hofheinz RD, Gnad-Vogt SU, Beyer U, Hochhaus A. Hofheinz RD, et al. Anticancer Drugs. 2005 Aug;16(7):691-707. doi: 10.1097/01.cad.0000167902.53039.5a. Anticancer Drugs. 2005. PMID: 16027517 Review.
171 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page